TON - January 2017, Vol 10, No 1

Advance care planning (ACP) continues to be a vital part of comprehensive, patient-centered cancer care, but barriers to uptake and implementation remain. Read More ›

Nurse Navigation Plays an Important Role at the Novant Health Derrick L. Davis Cancer Center
The Novant Health Oncology Specialists at the Novant Health Forsyth Medical Center provide world-class cancer care at the Derrick L. Davis Cancer Center in collaboration with the Maya Angelou Women’s Health & Wellness Center. Located in Winston-Salem, NC, the cancer center is accredited by the Commission on Cancer, offering comprehensive patient care along with the latest in diagnosis, treatment, research, support services, and genetics evaluation. Read More ›

The findings of 2 separate studies presented at the recent European Society for Medical Oncology (ESMO) Congress suggest that oncology nurses need more education and training on how to manage adverse effects from cancer and its treatment. Read More ›

  • Gaps in Use of Tyrosine Kinase Inhibitors in Medicare Beneficiaries with Chronic Myeloid Leukemia
  • Mutations Responsible for Relapse Despite PD-1 Therapy Uncovered in Melanoma
  • Ricolinostat Shows Promise in Patients with Relapsed or Refractory Multiple Myeloma
Read More ›

Prospective, observational, and multicenter trials have documented a dramatic increase in venous thromboembolism (VTE) in children with cancer over the past decade. Read More ›


AONN+ Annual Conference Deemed a Success
More than 1000 oncology nurse and patient navigators from across the United States and Canada gathered in Las Vegas for the Academy of Oncology Nurse & Patient Navigators (AONN+) Seventh Annual Navigation & Survivorship Conference. Read More ›

Noteworthy Numbers: Leukemia
Leukemia is the most common cancer in children and adolescents and represents almost 1 of 3 cancers found in these populations. Read More ›

The January issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses Read More ›

Toxicities Associated with Targeted Therapy and Immunotherapy Underreported in Published Studies
Most oncologists’ knowledge about toxicities associated with newer therapies comes mainly from clinical trials, but publications of clinical trial safety results may be misleading. Read More ›

Page 2 of 3


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: